13^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology July 24-25, 2017 Rome, Italy

ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “13^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoMed 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Clinical Trials.

The main theme of the conference is “Emerging Importance of Nanotechnology to Drive the Pharma Industry”.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Track-1: Nanomedicines and Biomedical Applications

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

Nanomaterials Conference, March 30-31, 2017, Madrid, Spain; Medical Nanotechnology Summit May 22-23, 2017,  Osaka, International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017 Osaka, Japan; 2^nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19^th  International Conference on Nanotechnology and Nanomedicine, July 9 - 10, 2017, Prague, Czech Republic; European Nanomedicine Meeting 2017, April  3-4, 2017, London, UK; 19^th International Conference on Nanotechnology and Nanomedicine, June 21 - 22, 2017, Vienna, Austria; 4^th World Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine, Royal Society-NanoTechnology and NanoScience.

Track-2: Pharmaceutical Nanotechnology

Nanotechnology is the science which deals with the processes that occur at molecular level and of nanolength scale size. The major studies in the nanotechnology include nanosized particles, their function and behaviour with respect to other systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. Nanotechnology is the ability to understand and control materials at the very smallest scales, from around 100 nm to the dimensions of single atoms; At this Nano scale the properties of these nanosized particles are vary from the conventional medicines.

Related Conferences:

International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Frankfurt, Germany; International Conference on Nanotechnology 2017, August 7-8, 2017, Beijing, China; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; 20^th International Conference and Expo on Nanoscience and Molecular Nanotechnology, Dec 19-20, 2017, Osaka, Japan; 2^nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Osaka, Japan; 14^th Global Experts Meeting on Nanomaterials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain; 8^th International Conference on Nanotechnology: Fundamentals and Applications (ICNFA'17), Jun 07-08, 2017, Rome, Italy; 2^nd International Conference on Nanobiotechnology (ICNB'17), April 5 - 6, 2017, Barcelona, Spain; Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine, Royal Society-NanoTechnology and NanoScience.

Track-3: Nanomedicine and Drug Delivery

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the pharmacokinetics of the drug or other related chemical entities in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor signaling and activity. Pharmaceutical nanotechnology is helpful in the field of pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Conferences:

International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 11^th World Drug Delivery Summit, October 16-18, 2017 New York, USA; 10^th International Conference on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017, London, UK; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Frankfurt, Germany; 8^th Global Drug Delivery Formulation & Expo, March 2017, Berlin, Germany; 2^nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Osaka, Japan; 14^th Global Experts Meeting on Nanomaterials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain; 8^th International Conference on Nanotechnology: Fundamentals and Applications (ICNFA'17), Jun 07-08, 2017, Rome, Italy; Nanotechnology and Nanoscience Student Association (NANSA), Canadian NanoBusiness Alliance, European NanoBusiness Association, International Association of NanoTechnology (IAN), British Society for Nanomedicine.

Track-4: Nano Pharmaceuticals

Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. Nanopharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance.

Nanomaterials Conference, March 30-31, 2017, Madrid, Spain; Medical Nanotechnology Summit May 22-23, 2017,  Osaka, International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017 Osaka, Japan; 2^nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19^th  International Conference on Nanotechnology and Nanomedicine, July 9 - 10, 2017, Prague, Czech Republic; European Nanomedicine Meeting 2017, April  3-4, 2017, London, UK; 19^th International Conference on Nanotechnology and Nanomedicine, June 21 - 22, 2017, Vienna, Austria; 4^th World Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), American Academy of Nanomedicine (AANM), Nanotechnology and Nanoscience Student Association (NANSA), Canadian NanoBusiness Alliance.

Track-5: Novel Drug Delivery Technology

Novel approaches of drug delivery systems helps to enhance the availability of the drug, safety, efficacy and patient compliance. These Novel systems enable the administration of drugs in various routes and help in improving bioavailability of the drug either by changing its course of action, pharmacokinetic parameters or by the releasing patterns at the site of action. Drug delivery has now become a versatile scientific field by involving the studies of both biopharmaceutics and pharmacokinetics. These novel systems are to provide novel strategies for the delivery of biologically active drug molecules to the targeted sites at the right dose and at the right time.

Related Conferences:

10^th International Conference on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017, London, UK; 11^th World Drug Delivery Summit, October 16-18, 2017 New York, USA; International Conference and Exhibition on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; World Congress on Controlled Release Formulations / World Congress on Sustained Release Formulations, June 12-14, 2017 Amsterdam, Netherlands; 2^nd Drug Formulation & Bioavailability Congress, May 8-10, 2017, Berlin, Germany; 7^th Annual American Drug Delivery and Formulation Summit 2017, Costa Mesa, USA; 2^nd European Conference on Pharmaceutics Novel dosage forms & innovative technologies, April 3-4, 2017, Krakow, Poland; World congress on Pharmaceutics & Drug Delivery Systems, June 29-July 01, Valencia, Spain; 2^nd International Conference on Bridging Innovations in Pharmaceutical, Medical and Bio Sciences, Feburary11 - 12 , 2017, Bhopal, India; SLAS2017, the Society’s flagship international Conference and Exhibition, February 4-8, 2017, Washington. DC, USA; International Association of Nanotechnology (IANT), American Association for the Advancement of Science, Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), American Academy of Nanomedicine (AANM).

Track-6: Nanotechnology for Targeted Drug Delivery

Nano drug delivery systems can be used to tune and regulate release pharmacokinetics, pharmacodynamics, solubility, immunocompatibility, cellular uptake, biodistribution and by reducing toxicity these will enhances therapeutic index of traditional pharmaceuticals. They can be used to deliver both small-molecular and macromolecular drugs. These nanoparticles mediated sustained release of drugs offer an advantage that the targeted delivery of drugs in the body is required to prevent the release of therapeutics at non-specific sites and unwanted side-effects. The conjugation of targeting moieties with drug-loaded nanoparticles can be used for receptor-mediated and targeted delivery. Such targeted nanoparticles have the characteristics of a perfect drug delivery system that tends to improve the therapeutic activity while reducing the toxic side effects of drugs.

Related Conferences:

International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 11^th World Drug Delivery Summit, October 16-18, 2017 New York, USA; 10^th International Conference on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017, London, UK; 20^th International Conference and Expo on Nanoscience and Molecular Nanotechnology, Dec 19-20, 2017, Osaka, Japan; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; Nanotechnology 2017, Aug 07- 08, 2017, Beijing, China; NFA 2017 — The 3^rd International Conference on Nanomaterials: Fundamentals and Applications, Oct 09-11, 2017, Slovakia, Europe; SLAS2017, the Society’s flagship international Conference and Exhibition, February 4-8, 2017, Washington. DC, USA; RDD Europe 2017, April 25-28, 2017,  Nice (Antibes), France; 13^th International Conference on Diffusion in Solids and Liquids - DSL2017, June 26-30, 2017, Vienna, Austria; American Association for the Advancement of Science, Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), American Academy of Nanomedicine (AANM), Nanotechnology and Nanoscience Student Association (NANSA).

Track-7: Nanotechnology for Paediatric Medicine

Nanotechnology is widely used for development of paediatric medicine based on its variable characteristics. The large surface to volume ratio characteristic of nanomaterials is helpful to inhibit bacteria attachment to the organs and promote nonbacterial cell adhesion. The unique surface energetics of nanomaterials because of their significantly greater surface area compared with micron-sized materials. Because of the tissue growing properties of nanomaterials and antimicrobial properties of both nanoparticles and Nano modified surfaces have a number of applications within paediatric medicine. Some of these applications include anti-infection, tissue regeneration, drug delivery, and bio-sensing.

Related Conferences:

International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 2^nd International Conference on Pediatric Oncology, August 28-30, 2017, Philadelphia, USA; 12^th Annual Pediatric Medicine Congress, August 28-30, 2017, Philadelphia, USA; 11^th International Conference on Clinical Pediatrics, June 29-July 1, 2017, London, UK; International Conference on Nanotechnology 2017, August 7-8, 2017, Beijing, China; World Summit on Pediatrics 2017, June 22-25, 2017, Rome, Italy; World Congress on Micro and Nano Manufacturing 2017, March 27-30, 2017, Kaohsiung, Taiwan; 13^th International Conference on Diffusion in Solids and Liquids - DSL2017, June 26-30, 2017, Vienna, Austria; International Nanomedicine Conference, July 03-05, 2017, Sydney, Australia; 2^nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; Korea Nano Technology Research Society, Nano Science and Technology Consortium (NSTC), Nanotechnology Industries Association (NIA), Royal Society - Nanotechnology and Nanoscience, Russian Society of Scanning Probe Microscopy and Nanotechnologies.

Track-8: Nanotechnology in Preclinical and Clinical Development

Nanotechnology is generating a major influence on preclinical and clinical drug development. Novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells without harming surrounding organs. Advancements in nanobiotechnology have led to the design of nanoparticle based new drug candidates that present a novel approach to medical diagnostics and therapeutics. The biocompatible designing of Nano devices used for drug delivery has increased the solubility and effectiveness of classical drugs, and has provided the technology required for the targeted delivery of encapsulated tissue-organ specific therapeutics.

Related Conferences:

3^rd International Conference on Advanced Clinical Research and Clinical Trials, June 19-20, 2017, London, UK; International Conference on Nanotechnology 2017, August 7-8, 2017 Beijing, China; International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 20^th International Conference and Expo on Nanoscience and Molecular Nanotechnology, Dec 19-20, 2017, Osaka, Japan; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; World Preclinical Congress 2017, June 13-15, 2017, Boston USA; ICTO2017 — International Congress on Clinical Trials in Oncology and Hemato-Oncology, Mar 16- 17, 2017, London, UK; Clinical Trial Supply Europe 2017, March 15-16, 2017, Barcelona, Spain; Clinical Trial Collaborations, April 3-4, 2017, Boston, USA; ACRP 2017 Meeting & Expo, April 29-May 2, 2017, Seattle, USA; American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine, Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT).

Track-9: Regulatory Guidance for Pharmaceutical Nanotechnology

Nanotechnology represents a platform for developing revolutionary changes and improvements to many different aspects of pharmaceutical manufacturing. Also, the rate of nanotechnology discovery is proceeding more rapidly than practical applications can be found. Nanotechnology offers potential in pharmaceuticals for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenerative medicine. Although there is no international regulation or legislation specifically for nanomedicine, it is agreed worldwide that considerably more attention should be paid to the quality, safety, and efficacy of nanotechnology-based drugs. The US FDA and the European Medicines Agency have provided several regulatory guidelines for the development of nanomedicines.

Related Conferences:

World Congress on Regulations of Nanotechnology, July 11-12, 2017, Chicago, USA; 7^th International Conference on Pharmaceutical Regulatory Affairs and IPR, Sep 25-26, 2017, Chicago, USA; 10^th Nanotechnology Conference, Sep 10-11, 2017, London, UK; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; 2^nd International Conference on Nanomaterials, Nanodevices, Fabrication and Characterization (ICNNFC'17), April 5 - 6, 2017, Barcelona, Spain; 8^th International Conference on Advanced Materials and Nanotechnology, February 12-16, 2017, Queenstown, New Zealand; 2^nd International Conference on Nanotechnology and Material Science, July 27-28, 2017, Suzhou, China; International Nanomedicine Conference, July 03-05, 2017, Sydney, Australia; 3^rd International Congress On Technology - Engineering & Science, February 09 -10, 2017, Malaysia; Canadian NanoBusiness Alliance, European NanoBusiness Association, International Association of NanoTechnology (IAN), British Society for Nanomedicine, Czech Nanotechnology Industries Association.

Track-10: Future Aspects of Pharmaceutical Nanotechnology

Nanotechnology helps us economically to build a wide range of complex molecular devices by manipulating the structures on an atomic and molecular scale. Nanotechnology may be able to synthesize many new materials and devices with at least one dimension sized from 1 to 100 nm with a wide range of applications in pharmaceuticals. Future aspects of Nanotechnology in pharmaceuticals involve applications of nanoparticles, development of nano-robotics for cellular level repairing and also to develop Nano generators and Nano pore sequencing.

Related Conferences:

19^th Nanotek Conference November 13-14, 2017, Chicago, USA; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017 Osaka, Japan; 20^th International Conference on Nanoscience & Molecular Nanotechnology, Dec 19-20, 2017, Osaka, Japan; World Congress on Regulations of Nanotechnology July 11-12, 2017, Chicago, USA; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA;; The Eleventh International Conference on Quantum, Nano/Bio, and Micro Technologies, September 10 - 14, 2017, Rome, Italy; 3^rd International Conference on Nanomaterials, Fundamentals and Applications (NFA 2017), 09 - 11 October 2017, Slovakia, Europe; NanoWorld Conference, April 03-05, 2017, Boston USA; 4th World Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain; Erwin Schrödinger Society for Nanosciences, European Society for Precision Engineering and Nanotechnology (EUSPEN), International Association of Nanotechnology, Korea Nano Technology Research Society, Nano Science and Technology Consortium (NSTC).

Track-11: Recent Advances in Nanotechnology

Nano materials and devices play a major role in the field of pharmaceutical nanotechnology.  Nanomaterials  exhibit  properties  remarkably  different  from the  properties  of  the  bulk  material due to the large surface area to volume ratio that increases the solubility and rate of absorption. Novel nanostructures will helpful for use as artificial tissue engineering and also help to integrate nanodevices with the nervous system that will restore vision and hearing, and build artificial limbs through the implant of new tissue. Nanotechnology is applied in the pharmaceutical industry in such areas as nanomedicine, tissue engineering, nanorobotics, biosensors, biomarkers, image enhancement devices and implant technology. Investigations are currently being carried out on, among others, liposomes, dendrimers, metallic nanoparticles, polymeric nanoparticles, CNTs, quantum dots and nanofibres.

Related Conferences:

International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; 17^th Nanotechnology Products and Expo, Sep 17-18, 2017, Seoul, South Korea; 7^th International Conference on Pharmaceutical Regulatory Affairs and IPR, Sep 25-26, 2017, Chicago, USA; 10^th Nanotechnology Conference, Sep 10-11, 2017, London, UK; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; 4^th World Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain; 5^th International Conference on Nano and Materials Engineering (ICNME 2017), April 01-03, 2017, Bali, Indonesia; International Nanomedicine Conference, July 03-05, 2017, Sydney, Australia; Nanotech 2017 Conference & Expo, May 14-17, 2017, Washington DC, USA; 13^th International Conference on Diffusion in Solids and Liquids - DSL2017, June 26-30, 2017, Vienna, Austria; Nanotechnology Industries Association (NIA), Royal Society - Nanotechnology and Nanoscience, Russian Society of Scanning Probe Microscopy and Nanotechnologies, Nano Canadian Society, American Nano Society.

Track-12: Major Challenges in Nanotechnology

At present, nanotechnology has been widely applied to the area of drug development. Nanoparticle-based therapeutics has the ability to overcome biological barriers and to deliver hydrophobic drugs and biologics effectively to the target sites of disease. The complexity of nanoparticles as multi-component 3D structures require careful design and engineering and reproducible scale-up and manufacturing process to achieve a consistent product. The safety and efficacy of nanoparticle-based medicines can be influenced by minor variations in multiple parameters and need to be carefully examined in preclinical and clinical examinations. Finally, nanoparticle-based medicines may have to represent additional development challenges and regulatory considerations compared with conventional medicines. Efforts are being made to produce unique category of therapeutic agents while there is generally a lack of regulatory standards in the examination of nanoparticle-based medicines.

Related Conferences:

World Congress on Regulations of Nanotechnology, July 11-12, 2017, Chicago, USA; 7^th International Conference on Pharmaceutical Regulatory Affairs and IPR, Sep 25-26, 2017, Chicago, USA; 10^th Nanotechnology Conference, Sep 10-11, 2017 London, UK; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; Nano World Conference, April 03-05, 2017, Boston, USA; 13^th International Conference on Diffusion in Solids and Liquids - DSL2017, June 26-30, 2017, Vienna, Austria; The Eleventh International Conference on Quantum, Nano/Bio, and Micro Technologies, September 10 - 14, 2017 - Rome, Italy; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Osaka, Japan; 14^th Global Experts Meeting on Nanomaterials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain; American Society for Nanomedicine, Society for Personalized Nanomedicine, Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT), American Association for the Advancement of Science.

Track-13: Pharmaceutical Companies and Markets

Nano-enabled medical products have made their impact on the following areas such as cancer, CNS diseases, cardiovascular disease, and infection control. Among these cancer is one of the largest therapeutic area in which nano-enabled products have made their major contributions. Cancer is a prime focus for nano pharmaceutical R&D, and companies with clinical-stage developments. The nanomedicine market is in early growth. While nano-enhanced drug delivery products are already a commercial reality, more advanced nanotech-based medical devices are still in development, although some are at the clinical testing stage. Most of the money being spent on the wider field of nanotechnology R&D comes from government and established corporations. In the nanomedicine field, pharmaceutical and specialist companies are at the forefront of research into the medical applications of nanotechnology.

Related Conferences:

International Conference on Nanomedicine and Drug Delivery, May 29-31, 2017, Osaka, Japan; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Frankfurt, Germany; International Conference on Nanotechnology 2017, August 7-8, 2017 Beijing, China; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; 20^th International Conference and Expo on Nanoscience and Molecular Nanotechnology, Dec 19-20, 2017, Osaka, Japan; International Nanotechnology Exhibition & Conference, February 15-17, 2017, Tokyo, Japan; International Conference on Nanosciences & Nanotechnologies (NN17), July 4-7, 2017, Thessaloniki, Greece; 7^th NANOTEXNOLOGY Expo 2017, July 03-07, 2017,  Thessaloniki, Greece; 5^th International Conference on Nano and Materials Science ICNMS 2017, January 19-21, 2017, San Diego, USA; 15^th World Medical Nanotechnology Congress & Expo, May 22-23, 2017, Osaka, Japan; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), American Academy of Nanomedicine (AANM), Nanotechnology and Nanoscience Student Association (NANSA), Canadian NanoBusiness Alliance.

Track-14: Business Opportunities in Nanotechnology

In 2008 more than $18 billion was invested in nanotechnology R&D by private and public sector companies worldwide with substantial portions in the areas of health and medicine. Upon ageing of population and increasing costs of healthcare, the focus is shifting from managing health to preventative measures. Hence better diagnostic Nano devices and targeted therapeutics with smart drug delivery devices will be in higher demand. Advancements in Nanotechnology will not only improve efficacy and reduce side effects of existing drugs but also will enable a faster discovery process to eliminate non-efficacious drugs with less investment and in a little time. Similarly, these advancements in nanotechnologies will shorten the drug development process and get more drugs to market quicker.

Related Conferences:

World Congress on Regulations of Nanotechnology, July 11-12, 2017, Chicago, USA; 7^th International Conference on Pharmaceutical Regulatory Affairs and IPR, Sep 25-26, 2017, Chicago, USA; 10^th Nanotechnology Conference, Sep 10-11, 2017 London, UK; 16^th World Nano Conference, June 5-6, 2017, Milan, Italy; International Conference on Nanobiotechnology, July 10-11, 2017, Chicago, USA; 4^th World Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain; 5^th International Conference on Nano and Materials Engineering (ICNME 2017), April 01-03, 2017, Bali, Indonesia; International Nanomedicine Conference, July 03-05, 2017, Sydney, Australia; Nanotech 2017 Conference & Expo, May 14-17, 2017, Washington DC, USA; 13^th International Conference on Diffusion in Solids and Liquids - DSL2017, June 26-30, 2017, Vienna, Austria; European NanoBusiness Association, International Association of NanoTechnology (IAN), British Society for Nanomedicine, Czech Nanotechnology Industries Association, Erwin Schrödinger Society for Nanosciences.